Raymond James Financial Inc. Buys New Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Raymond James Financial Inc. bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 501,734 shares of the company's stock, valued at approximately $34,720,000. Raymond James Financial Inc. owned about 0.40% of Henry Schein as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of HSIC. Versant Capital Management Inc boosted its stake in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after acquiring an additional 335 shares in the last quarter. Venturi Wealth Management LLC boosted its holdings in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC increased its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after buying an additional 143 shares in the last quarter. Finally, City State Bank purchased a new stake in shares of Henry Schein in the fourth quarter worth $55,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Henry Schein Price Performance

HSIC stock traded down $2.14 during trading on Monday, hitting $62.59. The company had a trading volume of 378,260 shares, compared to its average volume of 1,612,109. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average of $70.41 and a 200 day moving average of $71.98. The firm has a market capitalization of $7.67 billion, a price-to-earnings ratio of 25.76, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 EPS. As a group, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on HSIC shares. Barrington Research reissued an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and boosted their price objective for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. UBS Group cut their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Wells Fargo & Company assumed coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 target price on the stock. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.